Francois Kress

Co-Founder & CEO FRERE | Health Tech CEO | Experienced Luxury and Fashion Global CEO | Ecole Polytechnique

📍 New York, New York, United States🔄 Updated July 2026💼 5 investments📅 16 years investing🗓 Last invested Jun 2023𝕏 @upgrade_to_unlock
Operator-angel🌍 United States
5
Total investments
1
Early stage
0
Mid stage
1
Late stage
16y
Years active

Portfolio

4 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jun 2023
A Certified B Corporation, Another Tomorrow pushes the boundaries of what responsibly grown and ethically manufactured materials can achieve. Sensual and strong, our collection is designed for living. Our platform for a technology-based circular economy was built on modern business principles of community, transparency, and organic scarcity. Every decision has been guided by a value system based on three pillars – human, animal, and environmental welfare. Using fashion as a pathway to activism, we seek to model what is possible at this critical juncture in our humanity - amplifying voices for change, educating and engaging our community with the stories behind our clothes, and providing more information about supply chains at large.
Board Member
Feb 2023
REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia.
Board Member
Jun 2016
MyndBlue is a digital MedTech company specializing in major depressive disorder (MDD), post-traumatic stress disorder (PTSD) and artificial intelligence. MyndBlue is developing a personalized and predictive clinical score combining physiological measurements from outpatients, machine learning, and artificial intelligence. MyndBlue's mission is to enable physicians to conduct objective clinical monitoring of their patients during and distance from consultations, intervene earlier through real-time detection of complications, and predict the trajectory of the disease to anticipate crisis and relapse. MyndBlue aims to provide patients with optimal treatment to increase their recovery rate and chances of regaining a high-quality life.
Board Member
Sep 2015
TrueFacet is the trusted jewelry marketplace for buyers and sellers of branded jewelry, watches, and handbags – backed with our authenticity promise and best price guaranteed. The company was founded (in New York) in December 2013 and acquired in 2020. Co-Owners are: Raj Seecharran (CEO) Robert Koptiev (President) and Lawrence Levinson (General Counsel) Raj has over 15 years of experience in investment banking markets and technologies, where he held trading and operations roles in management leveraging technology to drive efficiencies in inefficient markets by optimizing pricing and infrastructure to allow for scalability and capture substantial market share. Raj has adopted this experience across the jewelry industry since 2011, across several ventures in e-commerce, wholesale, and retail product marketing initiatives. Robert is a 2nd generation jeweler alongside his father in the New York family-owned business Gabriel Jewelry Refining, which has been one of the leading US jewelry wholesale distributors for over 35 years. Robert is responsible for maintaining and expanding the platform’s reach and network, ensuring the company’s strong link with the best names in the luxury industry. Lawrence, investor and systems engineer, and partner of Rob and Raj in LUXYSOURCE and ZAP-IT. With his law office co-located with TrueFacet NYC Diamond District, Larry brings on board a vast experience handling transaction from the biggest billion+ M&A mega deals, where he commanded over 50 lawyers and 20 law firms, to guiding numerous development stage companies. He achieved a prestigious Magna Cum Laude JD degree from Harvard Law School, BS Engineering from Princeton University, MS Engineering from NYU Poly Engineering and was a Grumman Aerospace Corporation Scholar who worked on the F-14 and E-2C.
Experience · 14 entries
All (14)
Investments (5)
Founder (6)
Board (5)
2024
Co-Founder and CEO
Mar 2024
Coming Fall 2024: Experience a revolution in mens luxury fashion with FRÈRE. Our brand pioneers a new era of sophistication, blending traditional craftsmanship with modern design. Each meticulously crafted garment, made in Italy, embodies vibrant luxury and enduring sophistication, setting a new standard for sartorial excellence. Join us as we redefine contemporary menswear, one stitch at a time. For made-to-measure inquiries, please email us at bespoke@frereny.com
2023
Board Member
Jun 2023
A Certified B Corporation, Another Tomorrow pushes the boundaries of what responsibly grown and ethically manufactured materials can achieve. Sensual and strong, our collection is designed for living. Our platform for a technology-based circular economy was built on modern business principles of community, transparency, and organic scarcity. Every decision has been guided by a value system based on three pillars – human, animal, and environmental welfare. Using fashion as a pathway to activism, we seek to model what is possible at this critical juncture in our humanity - amplifying voices for change, educating and engaging our community with the stories behind our clothes, and providing more information about supply chains at large.
Board Member
Feb 2023
REGEnLIFE is an innovative company developing cutting-edge therapy for neurodegenerative disorders. Our company supports a non-invasive medical approach based on physical sciences. Our mission is to develop innovative and responsible technologies to face up to medical challenges and public health needs. Our goal is to provide to healthcare professionals a technology able to alter the progression of neurodegenerative diseases, in order to improve the health and quality of life to promote a healthy aging process. Our technology consists in a novel medical device dedicated to people living with neurodegenerative diseases, specifically Alzheimer-type dementia.
2017
Co-Founder & CEO
Oct 2017
COVE, the stress-canceling wearable by Feelmore Labs is now available for purchase at feelcove.com. Feelmore Labs is a health and wellness technology company headquartered in New York City, pioneering a new category of wearable devices that improve lives by training and tuning the nervous system to help people feel and perform better every day. Feelmore Labs is backed by major venture capital firms including True Ventures, ARCH Venture Partners, and M13 and is led by a diverse team of scientists, medical professionals, and business and technology executives spanning the luxury consumer goods, professional sports, and technology industries, among others. Our scientific advisory board is made up of experts in neuromodulation, mood disorders, and sleep science from top institutions including Brown University and Harvard Medical School. To learn more about Feelmore Labs, go to www.feelmorelabs.com. For press inquiries please email press@feelmorelabs.com.
2016
Board Member
Jun 2016
MyndBlue is a digital MedTech company specializing in major depressive disorder (MDD), post-traumatic stress disorder (PTSD) and artificial intelligence. MyndBlue is developing a personalized and predictive clinical score combining physiological measurements from outpatients, machine learning, and artificial intelligence. MyndBlue's mission is to enable physicians to conduct objective clinical monitoring of their patients during and distance from consultations, intervene earlier through real-time detection of complications, and predict the trajectory of the disease to anticipate crisis and relapse. MyndBlue aims to provide patients with optimal treatment to increase their recovery rate and chances of regaining a high-quality life.
Show all 14 entries ↓
Investment activity
2010–2023 · 5 investments
20101201512016120232
Recent (last 2 years)Earlier